Brent Standridge, Chief Operating Officer at ARATANA THERAPEUTICS, INC. (PETX), sold 10,000 shares at $6.11 ($61K) on 2017-09-25, disclosed to the SEC on 2017-09-27.
Open-market sale of $61k PETX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.